Literature DB >> 29325608

Mitochondrial diseases.

Ryan L Davis1, Christina Liang2, Carolyn M Sue3.   

Abstract

Mitochondrial diseases collectively describe a diverse group of heritable disorders that invariably affect mitochondrial respiratory chain function and cellular energy production. Together they represent the most common cause of inherited metabolic disease, may present at any age, have a wide spectrum of clinical manifestations, may be insidious in onset, and potentially have high morbidity and mortality. Due to the presence of mitochondria in all nucleated cells, mitochondrial disease can affect many different tissues, with single or multiple systems being involved. This leads to highly variable presentations, making the diagnosis of mitochondrial diseases challenging. Recent advances in biomarker and genetic testing, coupled with emerging treatments and reproductive options, hold great promise for improving the clinical identification and management of this highly mutable disease group.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  FGF-21; GDF-15; biomarkers; inherited metabolic disease; mitochondrial disease; mtDNA

Mesh:

Substances:

Year:  2018        PMID: 29325608     DOI: 10.1016/B978-0-444-63233-3.00010-5

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  5 in total

1.  Mitochondrial donation: is Australia ready?

Authors:  Marie A Dziadek; Carolyn M Sue
Journal:  Med J Aust       Date:  2021-10-31       Impact factor: 12.776

Review 2.  Diseases Caused by Mutations in Mitochondrial Carrier Genes SLC25: A Review.

Authors:  Ferdinando Palmieri; Pasquale Scarcia; Magnus Monné
Journal:  Biomolecules       Date:  2020-04-23

3.  Altered Plasma Mitochondrial Metabolites in Persistently Symptomatic Individuals after a GBCA-Assisted MRI.

Authors:  DeAunne Denmark; Ilene Ruhoy; Bryan Wittmann; Haleh Ashki; Lorrin M Koran
Journal:  Toxics       Date:  2022-01-26

4.  Two Chinese siblings of combined oxidative phosphorylation deficiency 14 caused by compound heterozygous variants in FARS2.

Authors:  Liangshan Li; Jianhua Ma; Jingli Wang; Liping Dong; Shiguo Liu
Journal:  Eur J Med Res       Date:  2022-09-26       Impact factor: 4.981

5.  Delayed diagnoses of mitochondrial cytopathies in patients presenting with end stage kidney disease: two case reports.

Authors:  Tayeba Roper; Mark Harber; Gareth Jones; Robert D S Pitceathly; Alan D Salama
Journal:  BMC Nephrol       Date:  2020-08-24       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.